MedTrace Logo

Landscape of Gout in French Polynesia.

NCT07343336 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2750

Last updated 2026-01-15

No results posted yet for this study

Summary

The aim of this research is to characterise the genetic and molecular landscape of gout, inflammation and metabolic diseases, as well as the associated molecular, anthropomorphic and pathological characteristics.

Conditions

Interventions

OTHER

Epidemiological study

Collection of sociodemographic data, collection of treatment data, standard and clinical ophthalmological examination, physical and biological measurements, clinical characteristics specific to chronic and metabolic diseases, questionnaires (gout questionnaire, health assessment questionnaire (HAQ-II), EuroQol (EQ)-5D-5L, joint pain, state of health, diet and physical activity, access to care, addictions, sleep quality, pain scale (EVA), personal and family history) will be performed.

DIAGNOSTIC_TEST

Blood and urine tests

Collection of blood and urine samples for genetic, biochemical, omics, and biobank analyses, in order to characterize cardiometabolic health markers will be performed.

Sponsors & Collaborators

  • Variant Bio, Inc.

    collaborator UNKNOWN

  • Lille Catholic University

    lead OTHER

Principal Investigators

  • Tristan Pascart, Professor · GHICL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-02
Primary Completion
2027-09-30
Completion
2027-09-30

Countries

  • French Polynesia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07343336 on ClinicalTrials.gov